Results 251 to 260 of about 105,016 (295)
Acetate ameliorates membranous nephropathy by modulating the immune response and podocyte function. [PDF]
Liu J +5 more
europepmc +1 more source
Value of multiparametric MRI as a potential marker to differentiate membranous nephropathy from IgA nephropathy. [PDF]
Shi R +11 more
europepmc +1 more source
The lipid-podocyte axis: emerging clues in membranous nephropathy pathogenesis. [PDF]
Ma S +6 more
europepmc +1 more source
A retrospective study of the efficacy and safety of rituximab biosimilar for the treatment of membranous nephropathy. [PDF]
Zou YZ +5 more
europepmc +1 more source
Characteristics of the gut mycobiome in patients with membranous nephropathy. [PDF]
Zhi Y +6 more
europepmc +1 more source
Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults, it is the most frequent cause of nephrotic syndrome. In ~80% of patients, there is no underlying cause of MN (primary MN) and the remaining cases are associated with medications or other diseases such as systemic lupus erythematosus, hepatitis virus infection or ...
Allison Tong +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Immunosuppression for membranous nephropathy
The Lancet, 2013Item does not contain ...
Hofstra, J.M., Wetzels, J.
+14 more sources
Segmental membranous nephropathy
Clinical and Experimental Nephrology, 2021Most cases of membranous nephropathy (MGN) present with global and diffuse distribution of subepithelial deposits. However, segmental MGN, in which there is focal or diffuse segmental subepithelial deposits, are occasionally encountered. The clinical and pathologic significance of segmental MGN is not well understood and thought to be more likely due ...
Hae Yoon Grace Choung, Bruce Goldman
openaire +2 more sources
Neural epidermal growth factor-like 1 proteinĀ (NELL-1) associated membranous nephropathy
Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively.
Michel Jadoul +2 more
exaly +2 more sources

